The findings of the present study demonstrated that IGF2BP2 together with PD-1/PD-L1 may serve as effective biomarkers for the diagnosis and prognosis of hypopharyngeal carcinoma. The gene discussed is PDCD1; the disease is hypopharyngeal carcinoma.